April 14, 2022
Murdo Gordon, EVP, Global Commercial Operations, Amgen Two years after the inception of its stand-alone operations in Japan, Amgen is gearing up for the launch of Lumakras (sotorasib) in the country, where the drug will join the reimbursement price list...read more